Recap: Larimar Therapeutics Q4 Earnings
Recap: Larimar Therapeutics Q4 Earnings
Larimar Therapeutics (NASDAQ:LRMR) reported its Q4 earnings results on Thursday, March 14, 2024 at 04:05 PM.
Larimar Therapeutics（纳斯达克股票代码：LRMR）于2024年3月14日星期四下午4点05分公布了其第四季度财报。
Here's what investors need to know about the announcement.
以下是投资者需要了解的有关该公告的信息。
Earnings
收益
Larimar Therapeutics missed estimated earnings by -20.0%, reporting an EPS of $-0.3 versus an estimate of $-0.25.
Larimar Therapeutics报告的每股收益为-0.3美元，未达到预期的-20.0％，而预期的收益为-0.25美元。
Revenue was down $0 from the same period last year.
收入比去年同期下降了0美元。
Past Earnings Performance
过去的收益表现
Last quarter the company beat on EPS by $0.01 which was followed by a 14.000000000000002% increase in the share price the next day.
上个季度，该公司的每股收益超过0.01美元，随后第二天股价上涨了14.0000000000002％。
** Listen to the earnings announcement yourself by clicking here. **
** 点击此处亲自收听财报公告。**
To track all earnings releases for Larimar Therapeutics visit their earnings calendar here.
要追踪Larimar Therapeutics发布的所有财报，请在此处访问他们的财报日历。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自动内容引擎生成，并由编辑审阅。